Drug Type AAV based gene therapy  | 
Synonyms-  | 
Target  | 
Action modulators  | 
Mechanism GJB2 modulators(gap junction protein beta 2 modulators)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Hearing Loss | Preclinical | France   | 02 Feb 2023 | 





